Joel Greenblatt’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$556K Buy
3,018
+2,038
+208% +$443K ﹤0.01% 1566
2026
Q2
$240K Buy
+980
New +$213K ﹤0.01% 1701
2020
Q1
– Sell
-2,495
Closed -$258K – 1076
2019
Q4
$258K Buy
+2,495
New +$101K ﹤0.01% 977
2019
Q3
– Sell
-11,158
Closed -$287K – 1088
2019
Q2
$287K Buy
+11,158
New +$224K ﹤0.01% 967

Other funds holding AXSM

Joel Greenblatt's AXSM Position: Q3 2026 in Review

Joel Greenblatt increased its Axsome Therapeutics (AXSM) stake by 208% in Q3 2026, buying an estimated $443K and bringing the position to 3,018 shares worth $556K. The position accounts for ﹤0.01% of the portfolio, ranked #1566.

Joel Greenblatt first reported a position in AXSM in Q2 2019 and has held it in 4 quarters since. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Joel Greenblatt held 3,018 shares of Axsome Therapeutics worth $556K as of Q3 2026.
  • Joel Greenblatt bought 2,038 Axsome Therapeutics shares in Q3 2026, an estimated $443K.
  • Axsome Therapeutics made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1566 holding.
  • Joel Greenblatt first reported a position in Axsome Therapeutics in Q2 2019 and has held it in 4 quarters since.
  • 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.